| 5/29/2024 | BKIG | Moody's gives A3 to Medtronic notes
|
| 5/29/2024 | BKIG | S&P rates Medtronic notes A
|
| 3/24/2023 | IG | New Issue: Medtronic details $2 billion of senior notes due 2028, 2033
|
| 3/23/2023 | IG | New Issue: Medtronic prices $2 billion of senior notes due 2028, 2033
|
| 3/23/2023 | IG | Medtronic to offer guaranteed senior notes in parts due 2028, 2033
|
| 3/23/2023 | BKIG | Moody’s rates Medtronic notes A3
|
| 9/29/2020 | IGLM | Medtronic to redeem seven series of outstanding notes in full
|
| 12/31/2019 | LM | Outlook 2020: Multi-billion-dollar tenders, exchanges lead liability management in 2019
|
| 7/10/2019 | IGLM | Medtronic gives pricing, early tender results for 14 series of notes
|
| 6/25/2019 | IGLM | Medtronic lifts cap on tender offer for 14 series to $4.35 billion
|
| 6/24/2019 | IGLM | Medtronic opens cash tender offer for up to $4.18 billion of notes
|
| 3/21/2018 | IG | Moody’s revises Medtronic to stable
|
| 3/22/2017 | IG | New Issue: Medtronic details $2 billion sale of notes in three tranches
|
| 3/21/2017 | IG | New Issue: Medtronic prices $2 billion three-part offering of senior notes, drops floaters
|
| 3/21/2017 | IG | Moody’s rates Medtronic notes A3
|
| 3/21/2017 | IG | Market Commentary: Morning Commentary: Investment-grade bond deal pipeline fills; Verizon weakens; Humana flat
|
| 3/21/2017 | IG | Medtronic plans sale of notes, with add-on to 4.625% notes due 2045
|
| 3/10/2017 | IG | Moody’s revises Medtronic to negative
|
| 7/14/2016 | BKIG | Moody’s ups Medtronic, Covidien to stable
|
| 6/27/2016 | CVLM | HeartWare: Holders may put or convert 3.5%, 1.75% notes after merger
|
| 4/14/2016 | IGLM | Medtronic sets pricing in tender offer, lifts tender cap to $3 billion
|
| 1/27/2015 | BKIG | Moody's downgrades Medtronic
|
| 1/27/2015 | BK | Medtronic draws $3 billion under term loan, amends revolver with close of Covidien acquisition
|
| 1/26/2015 | IG | S&P cuts Medtronic
|
| 12/31/2014 | IG | Market Commentary: Outlook 2015: High-grade primary’s momentum to continue into 2015; M&A drives activity
|
| 12/18/2014 | EMHYMUPFPV | Market Commentary: NWB prices add-on in week’s lone deal; Amazon.com firms; DirecTV unchanged
|
| 12/18/2014 | IG | Market Commentary: NWB prices add-on in week’s lone deal; Amazon.com firms; DirecTV unchanged
|
| 12/2/2014 | EMHYMUPFPV | Market Commentary: Amazon issues $6 billion; DirecTV, AmEx, Morgan Stanley also price; DirecTV tightens
|
| 12/2/2014 | IG | Market Commentary: Amazon issues $6 billion; DirecTV, Morgan Stanley also price; DirecTV tightens; Amazon better
|
| 12/1/2014 | EMHYMUPFPV | Market Commentary: Medtronic sells year’s largest deal; Berkshire Hathaway, Cox also price; Medtronic firms
|
| 12/1/2014 | IG | Market Commentary: Medtronic sells year’s largest deal; Berkshire Hathaway, Cox also price; Medtronic firms
|
| 12/1/2014 | IG | New Issue: Medtronic sells $17 billion of bonds in seven parts
|
| 12/1/2014 | IG | Moody’s applies A3 to Medtronic notes
|
| 12/1/2014 | IG | S&P: Medtronic notes rated AA-, on negative watch
|
| 12/1/2014 | IG | Medtronic sets guidance for seven-part notes offering; pricing Monday
|
| 11/10/2014 | BK | Medtronic gets new $11.3 billion bridge loan, $5 billion term loan
|
| 11/10/2014 | BK | S&P rates Medtronic loans AA-
|
| 10/3/2014 | IG | Moody’s might cut Medtronic
|
| 8/19/2014 | BKBWIG | Medtronic finishes Q1 with $12.8 billion of debt, is committed to Covidien acquisition
|
| 7/29/2014 | SP | New Issue: Credit Suisse prices $4.55 million 6.7% reverse convertibles linked to Medtronic
|
| 6/25/2014 | SPSW | Focus is on access, theme rather than structures amid tough pricing conditions, sources say
|
| 6/23/2014 | SP | New Issue: Credit Suisse prices $99 million 8% notes linked to Medtronic
|
| 6/18/2014 | BKIG | Medtronic gets $2.8 billion 364-day bridge loan commitment for buyout
|
| 6/16/2014 | BKCVIG | Medtronic has financing for $42.9 billion acquisition of Covidien
|
| 6/16/2014 | IG | S&P puts Medtronic on watch
|
| 2/21/2014 | IG | New Issue: Medtronic prices $2 billion senior notes in four tranches
|
| 2/20/2014 | CVIG | S&P rates Medtronic notes AA-
|
| 2/20/2014 | IG | Medtronic selling senior notes in three tranches
|
| 2/20/2014 | IG | Moody's assigns Medtronic notes A2
|
| 2/20/2014 | IG | Market Commentary: Canada, Google, Whirlpool deals price tight; Eli Lilly joins primary; Google eases, then firms
|
| 12/13/2013 | CVIG | S&P lifts Medtronic, debt
|
| 4/9/2013 | CV | Market Commentary: CEDC prints at 25; Alcoa slips 0.25 point on hedge; MGIC moves with shares; SunPower adds
|
| 4/8/2013 | CV | Medtronic adjusts conversion rate of 1.625% notes effective April 8
|
| 4/8/2013 | CV | Market Commentary: Medtronic convertibles trade ahead of maturity; Alcoa flat to up a hair; Colony gains
|
| 3/19/2013 | IG | New Issue: Medtronic prices $3 billion of five-, 10-, 30-year senior notes
|
| 3/19/2013 | IG | Market Commentary: Medtronic, BofA among issuers as tone rebounds; secondary spreads see continued widening
|
| 3/19/2013 | CVIG | Moody's: Medtronic notes A2
|
| 3/19/2013 | IG | Medtronic selling five-, 10-, 30-year senior notes Tuesday
|
| 3/18/2013 | CV | Market Commentary: Medtronic convertibles trade flat; AMR steady to higher at 110 and change; Medivation dips
|
| 3/15/2013 | CVIG | Moody's downgrades Medtronic
|
| 3/13/2013 | CV | Market Commentary: Salesforce slips below par; Iconix improves dollar neutral; iStar adds; Meadowbrook quiet
|
| 3/8/2013 | CVIG | Moody's could cut Medtronic
|
| 2/19/2013 | CV | Market Commentary: Central European Distribution jumps; AMR up; Cliff mandatory flat; Post, Forestar on tap
|
| 2/4/2013 | CV | Market Commentary: Gilead Sciences steady ahead of earnings; Medtronic active; SandRidge lower on trust news
|
| 1/15/2013 | CV | Market Commentary: Amgen sees sellers ahead of maturity; Gilead Ds better; Lennar slips; Pacira to price
|
| 1/14/2013 | CV | Market Commentary: Dendreon adds outright; InterMune intends to price notes, shares; Lennar earnings on tap
|
| 12/13/2012 | CV | Market Commentary: Cobalt slips from debut high; Clearwire jumps on Sprint offer; Endo Health moves lower
|
| 12/4/2012 | CV | Market Commentary: Volcano deal upsized, trades up in gray market; existing Volcano quiet; Seacor deal on tap
|
| 11/6/2012 | CV | Market Commentary: Intel, Medtronic convertibles top traders in quiet market; Electronic Arts trades in line
|
| 10/2/2012 | CV | Market Commentary: WellPoint adds in the gray, models attractively; Molina, Amerigroup quiet; Illumina eyed
|
| 9/28/2012 | CV | Market Commentary: ADM, Medtronic steady in active trade; GT Advanced adds on hedge; Iridium sells preferreds
|
| 9/7/2012 | CV | Market Commentary: Intel trades mixed to little changed after warning; NextEra adds 0.5 point dollar neutral
|
| 8/21/2012 | CV | Market Commentary: MolyCorp trades weakly on second day in the market; Medtronic active ahead of earnings
|
| 8/20/2012 | CV | Market Commentary: MolyCorp trades weakly on second day in the market; Medtronic active ahead of earnings
|
| 7/24/2012 | CV | Market Commentary: WebMD down on warning; Dendreon better on takeout rumor; Virgin Media tighter after earnings
|
| 7/5/2012 | CV | Market Commentary: Convertibles market quiet; Navistar steady before conference call; Patriot Coal around 30
|
| 6/12/2012 | SP | New Issue: UBS prices $149,964 3.87% trigger yield optimization notes linked to Medtronic
|
| 5/22/2012 | CV | Market Commentary: Patriot Coal slides on restructuring worries; other coal names weak; Kodak languishes
|
| 5/21/2012 | CV | Market Commentary: Kodak collapses on patent ruling; lesser credits weak; Newmont expands; SanDisk active
|
| 4/18/2012 | CV | Medtronic updates conversion rate of 1.625% convertibles due 2013
|
| 3/27/2012 | CV | Market Commentary: Lennar flat to slightly higher on hedge on earnings; Radian steady; Dendreon catches a bid
|
| 3/26/2012 | CV | Market Commentary: Investment-grade issues dominate convertibles market; Medtronic higher; MF Global dips
|
| 3/14/2012 | CVIG | S&P rates Medtronic notes A+
|
| 3/14/2012 | CVIG | Moody's: Medtronic notes A1
|
| 3/14/2012 | IG | New Issue: Medtronic prices $1.08 billion of 10-, 30-year senior notes
|
| 3/14/2012 | IG | Market Commentary: JPMorgan, Philip Morris, Medtronic, Nordea Bank price multi-part issues; bank paper firms
|
| 3/7/2012 | CVIG | S&P rates Medtronic notes A+
|
| 3/6/2012 | CVIGPF | Medtronic files automatic shelf covering stock, preferreds and debt
|
| 2/21/2012 | CV | Market Commentary: Gilead lower outright, mixed on hedge; SunPower, Suntech Power edge up; RadioShack adds
|
| 2/15/2012 | CV | Market Commentary: Teva trades in line after earnings; NetApp heavy ahead of earnings; Central European gains
|
| 2/14/2012 | CVIG | S&P lowers Medtronic, debt
|
| 1/9/2012 | CV | Market Commentary: Convertibles revert to 'quiet'; Alcoa firm to better ahead of earnings; Amgen steady
|
| 12/20/2011 | SP | New Issue: RBC prices $892,800 trigger phoenix autocallables linked to Medtronic
|
| 12/19/2011 | CV | Market Commentary: Amgen edges higher; Gilead mixed to higher; Jefferies lower; MF Global adds a few points
|
| 12/12/2011 | SP | RBC to price trigger phoenix autocallables linked to Medtronic
|
| 12/2/2011 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Medtronic
|
| 11/28/2011 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallables linked to Medtronic
|
| 11/22/2011 | CV | Market Commentary: Lennar launches new deal; Existing Lennar slips; Frontline tumbles; Gilead bounces some
|
| 10/21/2011 | CV | Market Commentary: SanDisk moves up on positive earnings; Old Nuance opens up; Investment-grade names active
|
| 10/20/2011 | CV | Market Commentary: Cubist improves dollar neutral; Ingersoll-Rand drops; low-premium names 'better for sale'
|
| 10/14/2011 | CV | Market Commentary: High-grade credits show strength; Microchip unchanged dollar neutral; Clearwire steady
|
| 10/13/2011 | CV | Market Commentary: Clearwire extends gains on positive quarterly figures; United Therapeutics paper unchanged
|
| 10/4/2011 | CV | Market Commentary: DryShips' convertibles slip; Overall market hit by weakness; MGM falls; AMR rallies
|
| 9/29/2011 | CV | Market Commentary: Kodak extends losses even as stock rises; AMD slips, shares plunge; Cemex trades in line
|
| 9/23/2011 | CV | Market Commentary: NuVasive seen as interesting story despite Medtronic issues; aircraft, airline space busy
|
| 9/21/2011 | CV | Market Commentary: Medtronic wins patent case against NuVasive; Human Genome gains; Alpha pulls down coal
|
| 9/19/2011 | CV | Market Commentary: Traders see flight to safety as Life Technologies, Medtronic active; Suntech declines
|
| 8/24/2011 | CV | Market Commentary: Hedge players win on United Therapeutics; Amerigroup adds; investment-grade paper active
|
| 8/22/2011 | CV | Market Commentary: Kodak adds premium points; Clearwire steady at higher levels; Medtronic, Amgen, EMC firm
|
| 8/12/2011 | CV | Market Commentary: Convertibles firm slightly; Tyson, United Rentals recouping; Microsoft little changed
|
| 8/11/2011 | CV | Market Commentary: High-grade paper mixed as strong equity rally cools convertibles; Bank of America in focus
|
| 7/20/2011 | CVIG | S&P: Medtronic view negative
|
| 6/29/2011 | CV | Market Commentary: Liquid names in trade; U.S. Steel lags underlying shares; Cameron trades ahead of call
|
| 6/15/2011 | CVIG | Moody's: Medtronic to negative
|
| 5/25/2011 | CV | Market Commentary: Horizon drops amid 'trading noise'; Medtronic mixed; Akorn's $100 million deal looks cheap
|
| 5/24/2011 | CV | Market Commentary: Cubist flat to lower amid takeover chatter; Medtronic 'for sale' after disappointing earnings
|
| 5/23/2011 | CV | Market Commentary: Cheniere Energy jumps outright on government support of LNG exports; BorgWarner slips
|
| 5/3/2011 | CV | Market Commentary: Mylan off outright, expands on hedge; Incyte premium comes in; Alaska Communications on tap
|
| 4/14/2011 | CV | Market Commentary: Dendreon slips a point on hedge; Medtronic Bs add as As hit maturity; Sunrise deal on tap
|
| 4/12/2011 | CV | Medtronic again adjusts conversion rate of 1.5% notes, 1.625% notes
|
| 3/10/2011 | CVIG | S&P rates Medtronic notes AA-
|
| 3/10/2011 | CVIG | Moody's: Medtronic notes A1
|
| 3/10/2011 | IG | New Issue: Medtronic prices $1 billion of five-, 10-year senior notes
|
| 3/10/2011 | IG | Market Commentary: Medtronic prices $1 billion of notes in two tranches; bond market weaker; bank paper widens
|
| 2/28/2011 | CV | Market Commentary: Thermo Fisher active, little changed on call; Medtronic, Medicis trade; primary picks up
|
| 1/25/2011 | CV | Citi says replace $15 billion of maturing converts with AngloGold, Boston Properties, among others
|
| 12/23/2010 | CV | Market Commentary: Convertibles quiet; Navistar sees low print after earnings; Medtronic firmer; GM flat
|
| 12/21/2010 | CV | Market Commentary: Symantec up 0.5 point on swap; Medtronic sees buyers; Ultrapetrol prices; Beacon Power to sell
|
| 12/13/2010 | CV | Market Commentary: A&P active, steady after bankruptcy filing; Home Inns & Hotels to price; Medtonic, Ford trade
|
| 11/24/2010 | CV | Market Commentary: Convertibles quiet ahead of Thanksgiving as positive data lifts shares; investors cautious
|
| 11/22/2010 | CV | Market Commentary: Tyson Foods gains dollar neutral; Tech Data adds outright; Kinross, Massey Energy active
|
| 9/9/2010 | CV | Market Commentary: JA Solar, Micron improve in active trade; Medtronic, Transocean steady; GT Solar on tap
|
| 8/26/2010 | CV | Market Commentary: Medtronic gains as bargain hunters lift stock; Newmont higher with gold; SanDisk struggles on
|
| 8/25/2010 | CV | Market Commentary: Lennar, Medtronic, Newmont gain with stocks; SanDisk stuck in negative; Transocean retreats
|
| 8/24/2010 | CV | Market Commentary: SanDisk slips further outright; Hornbeck sees trading spike; Medtronic firm with results
|
| 8/16/2010 | CV | Market Commentary: Convertibles muted; MannKind to price $100 million deal; King Pharma quiet as shares add
|
| 7/7/2010 | CV | Market Commentary: FTI Consulting richens despite revised outlook; Affymetrix steady; EMC gains after upgrade
|
| 7/2/2010 | CV | Market Commentary: Convertibles quiet; Lincare A paper improves dollar neutral; Informatica up; Helix firm
|
| 7/1/2010 | CV | Market Commentary: Amgen, Medtronic, Transocean trade in high volumes; ProLogis mixed; Ford price fluctuates
|
| 6/25/2010 | CV | Market Commentary: Convertible trading volume light; Transocean off; Medtronic flat; Avis, AMR under pressure
|
| 6/24/2010 | CV | Market Commentary: Shorter-dated high-grade names in trade; Transocean, Medtronic, Symantec in line; PPL up
|
| 5/27/2010 | CV | Market Commentary: Transocean rises, then pares gains; SunPower, NetApp up; Salix sells upsized $300 million
|
| 5/26/2010 | CV | Market Commentary: Convertibles better bid; Hertz, other in-the-money names improve; IG names dominate volume
|
| 5/25/2010 | CV | Market Commentary: Ford, Intel weaker as sell-off persists; Medtronic steady to lower after strong earnings
|
| 4/21/2010 | CV | Medtronic adjusts conversion rate on 1.5%, 1.625% convertible notes
|
| 4/1/2010 | CV | Market Commentary: Corporate Office slips on debut; Micron trades up in line after earnings; Medtronic active
|
| 3/17/2010 | IG | Market Commentary: SLM, Rockies Express sell split-rated notes, Narragansett Electric prices; banks trade hot
|
| 3/15/2010 | IG | Market Commentary: Commonwealth Bank, EIB, Entergy price bonds; trading volume down, Boston Scientific widens
|
| 3/12/2010 | IG | Market Commentary: Deutsche Bank prices trust preferreds, Eksportfinans, RenRe sell notes; Medtronic stays firm
|
| 3/11/2010 | IG | New Issue: Medtronic sells $3 billion of notes in five-, 10-, 30-year tranches
|
| 3/11/2010 | IG | Market Commentary: Medtronic, NStar, Columbus Southern price; more expected Friday; Medtronic gains in trading
|
| 3/11/2010 | CV | S&P rates Medtronic notes AA-
|
| 3/11/2010 | CV | Market Commentary: International Coal trades up on debut; Hologic higher in active trade; Smithfield active
|
| 2/1/2010 | CV | Market Commentary: Convertibles firmer; USEC better on Obama comments; Newmont Mining in trade as gold gains
|
| 1/25/2010 | CV | Market Commentary: EMC extends losses ahead of earnings; Amgen, Boston Properties little changed; UAL drops
|
| 1/20/2010 | CV | Market Commentary: U.S. Steel lower; Medtronic mixed; some health care names lower; Lexington Realty to price
|
| 1/4/2010 | CV | Market Commentary: Big cap, investment-grade names dominate convertibles trading: Amgen adds, Transocean mixed
|
| 12/8/2009 | CV | Market Commentary: Continental Airlines adds slightly on debut; Transocean firm; Golden Ocean cancels offering
|
| 12/7/2009 | CV | Market Commentary: Continental Airlines strengthen mildly in the gray; AMR strong; SunPower, solar names dip
|
| 12/3/2009 | CV | Market Commentary: Medtronic still active; CompuCredit sinks on dividend news; bank preferreds show gains
|
| 12/2/2009 | CV | Market Commentary: Convertibles players eye high-grade names; Medtronic, EMC in focus; Energy XXI talk emerges
|
| 11/25/2009 | CV | Market Commentary: Convertibles mostly quiet ahead of Thanksgiving break; Medtronic erases some gains; Ford down
|
| 11/24/2009 | CV | Market Commentary: Medtronic above par after earnings beat; Jefferies sinks; Cephalon rebounds after weakness
|
| 11/11/2009 | CV | Market Commentary: United Rentals trades above par; TeleCommunication higher; buyers boost Medtronic, Omnicare
|
| 10/6/2009 | CV | Market Commentary: MannKind drops on partnership deal delay; Medtronic, Transocean gain; Avis, AirTran plan deals
|
| 10/5/2009 | CV | Market Commentary: UAL adds amid quiet trading; AMD gains; Medtronic up in solid volume; trading breadth narrow
|
| 9/28/2009 | CV | Market Commentary: Convertibles quiet; AMR steady; Newmont strengthens; Aspect Medical change of control eyed
|
| 9/18/2009 | CV | Market Commentary: Kodak, Sonic issues gain on debuts; older paper higher; Newmont rises; D.R. Horton strong
|
| 8/27/2009 | CV | Market Commentary: NCI Building jumps on sweetened exchange; International Game gains; players eye primary
|
| 7/7/2009 | CV | Market Commentary: Vale gets tepid response in gray market; Medtronic, Transocean active; Chesapeake steady
|
| 5/20/2009 | CV | Market Commentary: FPL trades steady to slightly lower on debut; Hertz gains in gray; Cephalon launches deal
|
| 5/19/2009 | CV | Market Commentary: Convertibles drag in quiet trade; AngloGold edges up; new Covanta flat; Hertz, Saks to price
|
| 4/29/2009 | CV | Medtronic adjusts conversion rate on 1.5%, 1.625% convertible notes
|
| 4/21/2009 | CV | Market Commentary: KeyCorp, Medtronic lower; SBA adds on debut; Alexandria prices upsized $225 million deal
|
| 3/10/2009 | IG | New Issue: Medtronic gives terms for $1.25 billion notes in five-, 10-, 30-year tranches
|
| 3/10/2009 | IG | Market Commentary: Halliburton, Boeing, CVS, KeyCorp, Morgan Stanley among day's sales; Medtronic tightens
|
| 3/10/2009 | CV | Market Commentary: Johnson Controls sells upsized $750 million of convertibles; Medtronic, Alliant better; Beazer down
|
| 3/9/2009 | CV | S&P rates Medtronic note AA-
|
| 3/9/2009 | CV | Moody's gives Medtronic notes A1
|
| 3/9/2009 | CVIG | Medtronic files automatic shelf registration
|
| 3/9/2009 | IG | New Issue: Medtronic sells $1.25 billion senior notes in five-, 10-, 30-year tranches
|
| 3/9/2009 | IG | Market Commentary: GE Capital, Bank of America, Medtronic, PG&E sell notes; spread widen
|
| 2/23/2009 | CV | Market Commentary: Citigroup, Bank of America drop on sector fears; Medtronic gains on deals; Nasdaq slips but recommended
|
| 2/17/2009 | CV | Market Commentary: Selling hits convertibles: ON Semi drops, Micron, AMD weaker; Smithfield slips; Medtronic quiet
|
| 1/21/2009 | CV | Market Commentary: Financial preferreds bounce a little from big drop; health care, biotech names in trade; Avnet edges higher
|
| 1/7/2009 | CV | Market Commentary: Amgen, Medtronic succumb to profit taking; Intel up; Liberty/Time Warner in line despite warnings
|
| 12/19/2008 | SS | Medtronic completes acquisition of CryoCath
|
| 12/3/2008 | CV | Market Commentary: Alpha Natural drops 3 points dollar neutral on outlook; Schlumberger, Freeport also lower outlooks
|
| 11/18/2008 | CV | Market Commentary: Financials mostly weaker; Medtronic, Teva mixed; Digital River strong despite steep slide in shares
|
| 11/14/2008 | CV | Market Commentary: Convertibles mixed: EMC better; Amgen little changed to lower; Transocean wavers on weaker oil
|
| 11/10/2008 | CV | Market Commentary: AIG gains with boosted bailout, Medtronic adds; Nortel slides on quarterly loss; NRG Energy lower
|
| 11/4/2008 | CV | Market Commentary: Convertibles strengthen; ADM gains on earnings that beat estimates; Merrill, Prudential better
|
| 11/3/2008 | CV | Market Commentary: Virgin Media jumps on bank amendment; Ford unmoved by weak sales; Amgen, Medtronic up with stocks
|
| 10/16/2008 | CV | Market Commentary: Medtronic falls on report; Level 3 exchanges boost notes; AMR gains as oil slips; more buybacks possible
|
| 9/25/2008 | SS | Market Commentary: WaMu waits longer; Transmeta leads with Intel deal, possible sale; loose M&As cleaned up
|
| 8/29/2008 | CV | Market Commentary: Mylan, Medtronic trade flat to lower; Ambac gives back some gains; energy names quiet despite storm
|
| 8/19/2008 | CV | Market Commentary: Financials pummeled, Lehman, Wachovia hard hit; PDL BioPharma inks alliance with Bristol-Myers
|
| 7/21/2008 | CV | Market Commentary: Bank of America rallies on earnings; Countrywide firms as puts approach; Medtronic, Chesapeake gain
|
| 7/17/2008 | SS | Medtronic acquires Restore Medical for $29 million
|
| 7/11/2008 | CV | Market Commentary: Sellers slam Fannie Mae; Countrywide, Merrill, Webster, all lower; Medtronic, NII eke out gains
|
| 5/19/2008 | CV | Market Commentary: Huntington remains firm, but Sallie Mae weakens; Medtronic softer ahead of earnings, but Hologic adds
|
| 4/18/2008 | CV | Medtronic lifts conversion rate of 1.5%, 1.625% convertibles
|
| 3/25/2008 | CV | Market Commentary: Wyeth, Medtronic, Hologic trade; Bank of America lower, but Countrywide higher; MGIC prices
|
| 3/18/2008 | CV | Market Commentary: Convertibles mostly solidly higher; Countrywide, EMC, Medtronic add; WCI, Six Flags down
|
| 3/12/2008 | CV | Market Commentary: Convertibles mixed; Micron, ON Semiconductor rise; Thornburg surges; Suntech powers up
|
| 2/26/2008 | SP | New Issue: JPMorgan prices $1 million 11.95% notes linked to Medtronic, Boston Scientific
|
| 2/19/2008 | CV | Market Commentary: Convertibles mixed in quiet trade; Penske, Freeport-McMoRan higher; GM, Hologic lower; Medtronic flat
|
| 1/23/2008 | IG | Moody's rates Medtronic loan A1
|
| 11/20/2007 | CV | Market Commentary: Fannie Mae sneezes, germs spread to Countrywide; Beazer Homes down; Wright opens lower; Medtronic surges
|
| 11/2/2007 | CVIG | Moody's confirms Medtronic
|
| 11/2/2007 | SS | Merger of Medtronic, Kyphon complete
|
| 10/23/2007 | CV | Market Commentary: Level 3 hammered on earnings; Countrywide down on borrower bailout; Medtronic coming back?
|
| 10/22/2007 | CV | Market Commentary: Halliburton gushes; Intel rises; AMD, Micron sink; Medtronic slide continues; new offerings power SanDisk
|
| 10/19/2007 | CV | Market Commentary: Gilead falls after positive earnings; Medtronic drags down St. Jude; AMD weighs down Intel; Yahoo! gives back
|
| 10/18/2007 | CV | Market Commentary: CIT active but stays still; Medtronic continues slide; St. Jude down; Nektar tumbles as Pfizer pulls drug
|
| 10/16/2007 | CV | S&P: Medtronic unaffected
|
| 10/16/2007 | CV | Market Commentary: Medtronic recovers some; Intel down but not out; GM details batter Ford; LifePoint, Kodak down
|
| 10/16/2007 | SS | Kyphon stockholders approve Medtronic merger
|
| 10/15/2007 | CV | Market Commentary: Medtronic down on recall; resignation drives down Level 3; Tektronix surges with takeover
|
| 10/4/2007 | CV | Market Commentary: Intel, Micron recover; AMD moves up; Excel Maritime sets sail higher; Molina Healthcare eagerly anticipated
|
| 9/19/2007 | CV | Market Commentary: Countrywide, Beazer up with rates down; Medtronic rises on merger talk; AMD, XM stock and convertibles diverge
|
| 9/19/2007 | SS | Medtronic, Kyphon merger one step closer to completion with German approval
|
| 9/11/2007 | SS | Medtronic, Kyphon merger clears waiting period hurdle, deal could close in 1Q 2008
|
| 9/7/2007 | SS | Kyphon sets shareholder meeting date for Medtronic merger vote
|
| 8/28/2007 | CV | Market Commentary: PolyMedica convertibles skyrocket on takeover; AmeriCredit, Medtronic, slide; perfect storm slows volume
|
| 8/10/2007 | CV | Market Commentary: Schering-Plough makes debut; Countrywide battered by misunderstanding; market has 'choppy' Friday
|
| 7/27/2007 | SS | Market Commentary: Cadbury Schweppes postpones deal; Blackstone IPO sinks; Medtronic makes a deal; worst spreads in 5 years
|
| 7/27/2007 | BKCV | Moody's affirms Kyphon, may lower Medtronic
|
| 7/27/2007 | CV | Market Commentary: Medtronic, Amgen, EMC all active as investors run for cover; trading volume stays high
|
| 7/27/2007 | SS | Medtronic to grow spinal business with acquisition of Kyphon
|
| 7/12/2007 | CV | Market Commentary: Newmont strikes gold; Kendle continues strong; Molson Coors seen refreshing; Huntsman drops a peg
|
| 7/11/2007 | CV | Market Commentary: Newmont seen coming tight; Kendle, SonoSite active, CVRD moves higher again
|
| 7/10/2007 | CV | Market Commentary: Kendle, SonoSite talked cheap; Live Nation questioned; Medtronic, Mylan seen safe in choppy market
|
| 6/27/2007 | CV | Market Commentary: Gannett fails to excite; GSI Commerce goes big; IXYS backs out; Boston Private jumps in
|
| 6/26/2007 | CV | Market Commentary: Gannett jumbo deal, GSI issue on tap; Huntsman surges on merger; Amgen slides; Medtronic rises
|
| 4/18/2007 | CV | Medtronic adjusts conversion rate for 1.5%, 1.625% convertibles
|
| 2/21/2007 | CV | Market Commentary: Medtronic holds firm after lowered outlook; Level 3 climbs on ratings upgrade; XM remains active
|
| 2/15/2007 | CV | Market Commentary: Archer Daniels Midland bid strong in gray; Medtronic retreats; Ciena gains further; XM holds steady
|
| 1/9/2007 | CV | Market Commentary: Mills off on restatement, Chapter 11 risk; volatility lifts Peabody, Medtronic; Alexandria, Baldor plan deals
|
| 12/4/2006 | CV | S&P: Medtronic unaffected
|
| 11/22/2006 | CV | Market Commentary: Equity Office gains slightly; Medtronic unchanged after rally; Acquicor set price talk
|
| 11/21/2006 | CV | Market Commentary: Advanced Medical falls on recall; Medtronic climbs on results; Continental gains on merger hopes
|
| 10/24/2006 | BT | Medtronic: independent panel confirms Endeavor's low thrombosis rate at TCT stent safety session
|
| 10/18/2006 | CV | Market Commentary: St. Jude flat, drags Medtronic lower; AMR gains on profit; Home Properties, Minefinders quiet in the gray
|
| 9/25/2006 | BT | Medtronic gets FDA 510(k) clearance for aspiration catheter
|
| 9/19/2006 | BT | Medtronic devices receive FDA, Japanese approvals
|
| 9/18/2006 | BTCV | Medtronic says holders of 95.2% of convertibles exercise put option
|
| 9/15/2006 | BT | Medtronic kept at market outperform by JMP
|
| 9/15/2006 | BT | RBC keeps Medtronic at outperform
|
| 9/5/2006 | BT | MedTronic study says cardiac resynchronization therapy cost effective
|
| 8/30/2006 | BT | Medtronic's brain stimulation therapy effective in treating motor symptoms of Parkinson's disease
|
| 8/28/2006 | BT | Medusa closes $4 million financing; plans to expand into North American, U.K. markets
|
| 8/25/2006 | CV | Market Commentary: Ford gains on deal speculation; Tanger gains on REIT sentiment; Lucent, Medtronic unchanged
|
| 8/23/2006 | BT | RBC keeps Medtronic at outperform
|
| 8/23/2006 | BT | JMP maintains Medtronic at market outperform
|
| 8/14/2006 | BT | Orthofix, Medtronic end marketing services agreement
|
| 8/7/2006 | BT | Medtronic files automatic shelf registration for secondary offerings
|
| 8/3/2006 | CV | Market Commentary: Medtronic, DRS fall outright on poor guidance; Transocean slides on miss; CompuCredit declines
|
| 8/3/2006 | BT | JMP keeps Medtronic at outperform
|
| 8/3/2006 | BT | Medtronic maintained at outperform by RBC
|
| 8/2/2006 | CV | Market Commentary: Ford revs up on new advisor; Medtronic, St. Jude gain on Medicare changes; Huntsman gets results boost
|
| 7/19/2006 | BT | Resverlogix subsidiary RVX, Medtronic to develop ReVas technology in cardiovascular disease
|
| 7/17/2006 | BT | Medtronic granted FDA approval for continuous glucose monitoring system for diabetes
|
| 7/12/2006 | CV | Market Commentary: Genzyme, AAR jump outright with earnings; Archstone-Smith slows; Health Management gains further
|
| 7/10/2006 | BT | Medtronic to start DIAM spinal stabilization trials
|
| 7/7/2006 | BT | Medtronic's Cardiac Resynchronization Therapy approved in Japan
|
| 7/5/2006 | BT | Medtronic: FDA approves InterStim II System for treatment of overactive bladder, urinary retention
|
| 7/5/2006 | BT | JMP maintains Medtronic at market outperform
|
| 6/27/2006 | BT | Medtronic completes enrollment of trial for Endeavor coronary stent
|
| 6/20/2006 | CV | Market Commentary: Medtronic, Amgen fall prey to selling pressure; JetBlue adds; Actuant plunges
|
| 5/26/2006 | BT | Court rules Boston Scientific's products do not infringe Medtronic stent patents
|
| 5/24/2006 | BT | Medtronic at outperform by RBC
|
| 5/24/2006 | BT | JMP reiterates Medtronic at market outperform
|
| 5/24/2006 | CV | Market Commentary: Global Crossing, CBIZ gain in line on debuts; Midway sees narrow interest; Medtronic gets results boost
|
| 5/22/2006 | BT | Medtronic plans pivotal trials of treatments for overactive bladder, enlarged prostate
|
| 5/18/2006 | BT | Stereotaxis, Medtronic to study magnetic navigation in cardiac implants
|
| 5/17/2006 | BT | FDA approves Medtronic's new cardiac systems featuring distance wireless telemetry
|
| 5/17/2006 | BT | JMP keeps Medtronic at market outperform
|
| 5/12/2006 | CV | Market Commentary: Amkor, Manor Care gain on debuts; JDS Uniphase pulled down by stock; Global Crossing plans deal
|
| 5/9/2006 | BT | Medtronic to test device that combines implantable defibrillator with heart monitoring
|
| 5/1/2006 | BT | Medtronic gets FDA approval for small-vessel coronary stent
|
| 4/27/2006 | BT | Medtronic receives CE Mark for new carotid stent and filter
|
| 4/25/2006 | BT | Medtronic plans clinical trial of deep brain stimulation as depression treatment
|
| 4/24/2006 | CV | Market Commentary: Bausch and Lomb, Schlumberger get analysts' thumbs up; Halliburton, Medtronic shrug off reports
|
| 4/24/2006 | BT | Medtronic to invest in six new clinical trials
|
| 4/18/2006 | BTCV | Medtronic greenshoe exercised, upping 1.5%, 1.625% convertibles to $4.4 billion
|
| 4/17/2006 | BT | Medtronic sues Kyphon for patent infringement
|
| 4/17/2006 | CV | Market Commentary: Delta, JetBlue dive on oil, downgrades; Red Hat falls, Novell gains on Oracle CEO's comments
|
| 4/13/2006 | BT | Medtronic receives FDA approval for first insulin pump with continuous glucose monitoring
|
| 4/13/2006 | CV | Market Commentary: Medtronic gains dollar-neutral on debut; Bausch and Lomb rebounds before product pulled
|
| 4/13/2006 | BT | Medtronic gets FDA clearance for compact circulatory support system
|
| 4/12/2006 | BT | Medtronic kept at market outperform by JMP
|
| 4/12/2006 | CV | Market Commentary: Bausch and Lomb firms against falling stock; Cypress rebounds as Synaptics flattens; Rentech debut quiet
|
| 4/12/2006 | BTCV | New Issue: Medtronic prices $4 bln convertibles at 1.5%, up 10% for 5-year, 1.625%, up 10% for 7-year
|
| 4/11/2006 | BTCV | Medtronic $4 billion convertibles talked at 0.75%-1.5% for 5-years, 1%-1.75% for 7-years, both up 10%
|
| 4/11/2006 | BT | Market Commentary: NitroMed, Antigenics strike new lows; NPS Pharma, Insmed gain; Medtronic deal boosts Biomet
|
| 4/11/2006 | BTCV | S&P rates Medtronics' convertibles AA-
|
| 4/11/2006 | BTCV | Moody's rates Medtronic convertibles A1
|
| 4/11/2006 | CV | Market Commentary: Bausch and Lomb wider on product scare; Synaptics gains on iPod rumors; Medtronic plans $4 billion deal
|
| 4/5/2006 | BT | Bear Stearns reiterates Medtronic at outperform
|
| 4/5/2006 | BT | Medtronic cut to market outperform by JMP
|
| 3/28/2006 | BT | Medtronic sues Guidant in Ireland in ongoing stent patent infringement battle
|
| 3/27/2006 | BT | Cordis says district judge upholds patent infringement verdicts against Boston Scientific, Medtronic
|
| 3/27/2006 | BT | Medtronic's AneuRx stent approved by FDA
|
| 3/24/2006 | BT | Medtronic receives FDA approval for non-rechargeable neurostimulator
|
| 3/23/2006 | CV | Lehman plans $5.5 million issue of 1.5% notes linked to Medtronic
|
| 3/23/2006 | BT | Medtronic launches new defibrillator
|
| 3/23/2006 | BT | Medtronic wins stent patent arbitration with Cordis
|
| 3/17/2006 | CV | Market Commentary: General Motors falls in line with stock; Time Warner Telecom plans $200 million deal;
|
| 3/16/2006 | BT | FDA expands labeling of Medtronic's CRT pacing system for heart patients
|
| 3/14/2006 | BT | Medtronic says Endeavor stent shows consistent clinical efficacy, strong safety profile
|
| 2/22/2006 | BT | Bear Stearns puts Medtronic at outperform
|
| 2/22/2006 | BT | JMP puts Medtronic at strong buy
|
| 2/1/2006 | BT | Medtronic begins U.S. arm of Concerto defibrillator study
|
| 1/23/2006 | BT | Edwards Lifesciences, Medtronic settle patent infringement lawsuit
|
| 1/17/2006 | CV | Market Commentary: Convertibles move mostly lower as oil gains; Tyco, airlines drop, but Schlumberger adds
|
| 1/6/2006 | BT | JMP: St. Jude, Medtronic best bets in medical device stocks; still wary of orthopedics
|
| 12/13/2005 | BT | Medtronic enrolls first patient in trial for Endeavor's next generation drug-eluting stent
|
| 12/7/2005 | BT | Medtronic completes enrollment of Prestige LP Cervical Disc trial
|
| 11/29/2005 | BT | Medtronic's Vertex Reconstruction System approved for cranial stabilization
|
| 11/17/2005 | BT | JMP reiterates Medtronic strong buy
|
| 11/17/2005 | BT | Medtronic submits first part of approval request to FDA for thoracic stent graft system
|
| 11/8/2005 | CV | Market Commentary: Medtronic, Lucent, EDS, Cephalon lower in weak market; Blockbuster, Maverick, Equinix to price
|
| 11/4/2005 | CV | Market Commentary: Qwest, Chesapeake remain active; Celgene up, Emdeon lower; King sideways
|
| 11/2/2005 | CV | Market Commentary: Mercury rattles investors again; Chesapeake Energy prices, existing preferreds seen lower; Qwest mulled
|
| 11/1/2005 | BT | Medtronic brain pacemaker trial gets approval to continue from monitoring board
|
| 10/18/2005 | BT | JMP maintains Medtronic at strong buy
|
| 10/12/2005 | BT | Medtronic maintains strong buy rating
|
| 10/12/2005 | CV | Market Commentary: GM bonds extend slide; AMD drops; Best Buy lower; but Advanced Medical, Medtronic gain
|
| 10/3/2005 | BT | Medtronic maintained by Bear Stearns at market outperform
|
| 10/3/2005 | CV | Market Commentary: Celgene rebounds; Medtronic firm; School Specialty drops; NRG eyes $500 million mandatory preferred
|
| 9/27/2005 | BT | Medtronic initiated by JMP at strong buy
|
| 9/27/2005 | CV | Market Commentary: US Airways' convertible deal eyed; Nektar extends gains; but selling weighs on overall market
|
| 9/12/2005 | CV | Market Commentary: Northwest drops as other airline convertibles trade mixed; software names see better bids
|
| 9/12/2005 | CV | Moody's rates Medtronic notes A1
|
| 9/12/2005 | CV | S&P rates Medtronic notes AA-
|
| 8/23/2005 | CV | Market Commentary: Brocade convertibles move lower on call; Amylin gains outright but seen lower on a hedged basis
|
| 8/23/2005 | CV | Market Commentary: Brocade convertibles move lower on call; Amylin gains outright but seen lower on a hedged basis
|
| 6/29/2005 | BTCV | New Issue: Goldman Sachs prices $20 million notes exchangeable for Medtronic at 1%, up 14.25%
|
| 4/25/2005 | CV | Moody's rates Medtronic convertible A1
|
| 4/22/2005 | CV | S&P: Medtronic unaffected
|
| 1/24/2005 | CV | Medtronic exchanges 97.7% of 1.25% convertibles
|
| 1/10/2005 | CV | Medtronic extends exchange for 1.25% convertibles
|
| 12/17/2004 | CV | S&P rates Medtronic convertible AA-
|
| 12/14/2004 | CV | Medtronic starts exchange for 1.25% convertibles
|
| 11/18/2004 | CV | Market Commentary: XM Satellite deal seen at 98.75 but most new issues zoom; Sirius pounded; Williams hit
|
| 10/13/2004 | CV | S&P: Medtronic unaffected
|
| 10/4/2004 | CV | Market Commentary: Lehman deal exchangeable into General Mills bid up in gray market; Boston Private deal emerges
|
| 9/16/2004 | CV | Medtronic holders put $625,000 of 1.25% convertibles
|
| 6/24/2004 | CV | Market Commentary: Medtronic pat on 16% dividend boost; Kulicke & Soffa snubbed; Per-Se at 101.5; Rite Aid higher
|
| 5/25/2004 | CV | Market Commentary: Digital River, CSG deals emerge; Wild Oats at bat; Genworth edges up; Wyeth sinks; Calpine spikes
|
| 5/20/2004 | CV | New Issue: Goldman Sachs prices $10 million floaters exchangeable for Medtronic
|
| 4/6/2004 | CV | New Issue: Goldman Sachs $10 million 1.25% notes exchangeable for Medtronic yield 1.25%, up 31%
|
| 3/8/2004 | CV | Market Commentary: Medtronic, Wilson Greatbatch skip up on defibrillator implant trial results; market cheapens
|
| 11/13/2003 | CV | S&P: Medtronic ratings unaffected by stock repurchase
|
| 8/26/2003 | CV | Market Commentary: Mixed bag, as convertibles track stocks in another slow session; Xerox issue soars on dividend
|
| 9/17/2002 | CV | Medtronic says $38.7 million convertibles put back
|
| 9/6/2002 | CV | S&P confirms Qwest
|
| 9/6/2002 | CV | Market Commentary: Buyers emerge with new paper, improved tone in broader market
|
| 9/6/2002 | CV | Medtronic sells notes, obtains bank line to finance convertibles put
|
| 8/20/2002 | CV | Bear Stearns sees Medtronic offering put sweetener but says convertible worth holding anyway
|
| 7/17/2002 | CV | Deutsche foresees Medtronic offering sweetener to avoid put
|
| 6/25/2002 | CV | Bear Stearns recommends Medtronic on recent sell-off
|
| 5/17/2002 | CV | Deutsche recommends US Bancorp, Baxter, Medtronic, HCC, Markel as put sweetener trading ideas
|
| 5/9/2002 | CV | Market Commentary: Adelphia gains on asset sales news; Household lower on put speculation
|
| 12/18/2001 | CV | Deutsche analysts recommend Medtronic convert, saying cheapening limited
|
| 10/24/2001 | CV | UBS convertible analysts: stocks may not recover soon, so play defensive
|
